Center for Applied Proteomics and Molecular Medicine (CAPMM)

Mason start-up Ceres Nanosciences experiences big wins and increases footprint in Prince William County

Tue, 04/20/2021 - 08:49

Ceres Nanosciences, a Northern Virginia bioscience company spun out of George Mason University that specializes in diagnostic products and workflows, has opened a 12,000-square-foot advanced particle manufacturing plant in Prince William County’s Innovation Park.
Doctoral student combines love of lab research with practical applications

Mon, 03/29/2021 - 13:48

During the coronavirus pandemic, Mason doctoral student Marissa Howard was able to get back into the Center for Applied Proteomics and Molecular Medicine (CAPMM) lab, but now all the researchers are working on COVID-19-related research.
Mason COVID antibody testing shows a lot of promise in the body’s ability to fight the virus

Mon, 03/01/2021 - 16:10

COVID-19 antibody research by Mason scientists shows a lot of promise
Mason expands urine-based test for Lyme disease

Thu, 10/29/2020 - 05:00

A urine-based Lyme disease test created by a team of George Mason University researchers could soon become available statewide after a recent clinical validation study confirmed that it meets sensitivity and absolute molecular specificity standards.
Mason team sets the stage for a test that can detect tuberculosis in children

Mon, 08/24/2020 - 05:00
Mason student-athletes undergo COVID-19 testing as they return to campus

Thu, 08/13/2020 - 05:00
Mason researchers developing saliva test for COVID-19 antibodies

Tue, 04/28/2020 - 05:00
Galileo’s Science Cafés share Mason research with the community

Thu, 02/27/2020 - 05:00
Mason pioneers tackle concussion diagnosis and monitoring with saliva

Fri, 11/08/2019 - 19:30
Personalizing breast cancer treatments with multi-omics

Tue, 10/22/2019 - 15:07

Subscribe to Center for Applied Proteomics and Molecular Medicine (CAPMM)